Refine Search
(2)
(7)
(17)
(27)

Hyperlipidemia - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperlipidemia - Pipeline Review, H2 2016’, provides an overview of the Hyperlipidemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperlipidemia, ...

Lipodystrophy - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Lipodystrophy - Pipeline Review, H2 2016’, provides an overview of the Lipodystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Lipodystrophy, com...

Ageing - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ageing - Pipeline Review, H2 2016’, provides an overview of the Ageing pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ageing, complete with analysis b...

Hypertriglyceridemia - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypertriglyceridemia - Pipeline Review, H2 2016’, provides an overview of the Hypertriglyceridemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hype...

Diabetic Retinopathy - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Retinopathy - Pipeline Review, H1 2018’, provides an overview of the Diabetic Retinopathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diab...

Obesity - Pipeline Review, H1 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2018’, provides an overview of the Obesity pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Obesity, complete with analysi...

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2018’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) pipeline landscape.

The report provides comprehensive information on the therapeut...

Type 2 Diabetes - Pipeline Review, H1 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2018’, provides an overview of the Type 2 Diabetes pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Type 2 Diabete...

Hypercholesterolemia - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypercholesterolemia - Pipeline Review, H1 2018’, provides an overview of the Hypercholesterolemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hype...

Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2018’, provides an overview of the Pituitary ACTH Hypersecretion (Cushing Disease) pipeline landscape.

The report provides comprehensive info...

Hyperinsulinemia - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperinsulinemia - Pipeline Review, H1 2018’, provides an overview of the Hyperinsulinemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperinsulin...

Hyperglycemia - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperglycemia - Pipeline Review, H1 2018’, provides an overview of the Hyperglycemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperglycemia, com...

Familial Amyloid Neuropathies - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Familial Amyloid Neuropathies - Pipeline Review, H1 2018’, provides an overview of the Familial Amyloid Neuropathies pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Cushing's Syndrome - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cushing's Syndrome - Pipeline Review, H1 2018’, provides an overview of the Cushing's Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Hyperuricemia - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperuricemia - Pipeline Review, H2 2018’, provides an overview of the Hyperuricemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperuricemia, com...

Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2018’, provides an overview of the Proliferative Diabetic Retinopathy (PDR) pipeline landscape.

The report provides comprehensive information on the...

Post Menopausal Osteoporosis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Pipeline Review, H2 2018’, provides an overview of the Post Menopausal Osteoporosis pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Pompe Disease - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pompe Disease - Pipeline Review, H2 2018’, provides an overview of the Pompe Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pompe Disease, com...

Osteoporosis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteoporosis - Pipeline Review, H2 2018’, provides an overview of the Osteoporosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteoporosis, comple...

Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H2 2018’, provides an overview of the Homozygous Familial Hypercholesterolemia (HoFH) pipeline landscape.

The report provides comprehensive info...

Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2018’, provides an overview of the Heterozygous familial hypercholesterolemia (heFH) pipeline landscape.

The report provides comprehensive ...

Diabetic Foot Ulcers - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Foot Ulcers - Pipeline Review, H2 2018’, provides an overview of the Diabetic Foot Ulcers pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diab...

Diabetic Neuropathy - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Neuropathy - Pipeline Review, H2 2018’, provides an overview of the Diabetic Neuropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diabet...

Phenylketonuria (PKU) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Phenylketonuria (PKU) - Pipeline Review, H1 2019’, provides an overview of the Phenylketonuria (PKU) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ph...

Amyloidosis - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Amyloidosis - Pipeline Review, H1 2019’, provides an overview of the Amyloidosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Amyloidosis, complete ...

Insulin Resistance - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Insulin Resistance - Pipeline Review, H1 2019’, provides an overview of the Insulin Resistance pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Insulin ...

Hypoglycemia - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypoglycemia - Pipeline Review, H1 2019’, provides an overview of the Hypoglycemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hypoglycemia, comple...

Diabetic Macular Edema - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Macular Edema - Pipeline Review, H1 2019’, provides an overview of the Diabetic Macular Edema pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2019’, provides an overview of the Diabetic Peripheral Neuropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Dyslipidemia - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H1 2019’, provides an overview of the Dyslipidemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dyslipidemia, comple...

Diabetic Nephropathy - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Nephropathy - Pipeline Review, H1 2019’, provides an overview of the Diabetic Nephropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diab...